Smartwatch monitoring for atrial fibrillation burden
Part of Heart & circulation clinical trials.
This study tests whether a smartwatch can accurately measure how much time you spend in atrial fibrillation (an irregular heartbeat). By wearing a smartwatch, you may help find an easier way to track your condition without frequent clinic visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have atrial fibrillation (an irregular heartbeat) diagnosed by a doctor using an electrocardiogram (ECG).
- You must be willing to use long-range ECG monitoring equipment.
- You must not be allergic to electronic devices or unable to wear a watch.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a smartwatch can accurately track atrial fibrillation episodes after a catheter ablation procedure. It aims to provide a convenient way to monitor your heart rhythm without frequent clinic visits.
This study tests whether using a smartwatch to track how much time your heart is in AFib each day can help guide treatment. It aims to see if keeping AFib episodes low leads to better outcomes.
This study uses a smartwatch to track your heart and look for changes in your atrial fibrillation (irregular heartbeat) over time. It aims to learn more about how the condition progresses and the risk of stroke or blood clots, which may help improve future care.
This trial tests a smartwatch tool to track heart rhythm and detect problems in people with heart disease. It may help find irregular heartbeats early during routine checkups.
This study tests a special watch (the Corsano CardioWatch) that can detect an irregular heartbeat called atrial fibrillation. If you're already getting heart monitoring or have symptoms, this watch might be an easier way to track your heart rhythm over a few days.
This trial uses a smartwatch to monitor your heart remotely. It aims to improve health outcomes for people with acute heart failure who also have an irregular heartbeat called atrial fibrillation.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.